ID: ALA1963462

Max Phase: Preclinical

Molecular Formula: C21H32NO2+

Molecular Weight: 330.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@](C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)C1CCCC1

Standard InChI:  InChI=1S/C21H32NO2/c1-21(18-11-7-8-12-18,17-9-5-4-6-10-17)20(23)24-19-13-15-22(2,3)16-14-19/h4-6,9-10,18-19H,7-8,11-16H2,1-3H3/q+1/t21-/m1/s1

Standard InChI Key:  DVRRHBYHAIRKEY-OAQYLSRUSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.49Molecular Weight (Monoisotopic): 330.2428AlogP: 3.92#Rotatable Bonds: 4
Polar Surface Area: 26.30Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.12CX LogD: -0.12
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.62Np Likeness Score: 0.16

References

1. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]

Source